BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30
• 31

• Drug Development

  Arrowhead Research Corporation’s ARC-520 Leads To Consistent Immune Reactivation In Chimpanzees With Chronic Hepatitis B Infection

  December 7, 2015

   · 

  6 min read
• Pharm Country

  Celgene Release: IMiD Combination Therapies Form Backbone Of Multiple Myeloma Research At American Society of Hematology

  December 7, 2015

   · 

  1 min read
• Business

  Celgene In Collaboration With AstraZeneca PLC Announce Initiation Of Fusion Clinical Development Program In Immuno-Oncology

  December 7, 2015

   · 

  14 min read
• Drug Development

  Celgene Release: FDA Fast Track Designation Granted To Luspatercept For The Treatment Of Patients With Lower-Risk Myelodysplastic Syndromes

  December 7, 2015

   · 

  6 min read
• Drug Development

  Seattle Genetics Highlights Vadastuximab Talirine (SGN-CD33A) Data Presentations In Patients With Acute Myeloid Leukemia At American Society of Hematology 2015

  December 7, 2015

   · 

  11 min read
• Drug Development

  Merck & Co. Release: Responses Observed In Three-Quarters Of Heavily Pre-Treated Multiple Myeloma Patients Receiving KEYTRUDA (Pembrolizumab) Combined With Lenalidomide And Dexamethasone

  December 7, 2015

   · 

  14 min read
• Policy

  Health Canada Issues Notice Of Compliance For Gilead’s Single Tabletregimen Genvoya (Elvitegravir, Cobicistat, Emtricitabine And Tenofoviralafenamide) For Treatment Of HIV-1 Infection

  December 7, 2015

   · 

  5 min read
• Drug Development

  Genentech Release: Pivotal Phase II Study Showed Nearly 80 Percent Of People With Hard-To-Treat Type Of Chronic Lymphocytic Leukemia Responded To Investigational Medicine Venetoclax

  December 7, 2015

   · 

  7 min read
• Drug Development

  AbbVie Announces The New England Journal of Medicine Online Publication Of Venetoclax Phase 1 Data In Relapsed/Refractory Chronic Lymphocytic Leukemia

  December 7, 2015

   · 

  6 min read
• Drug Development

  Spectrum Pharma And Onxeo Announce Complete Response In 67% Of Patients With Peripheral T-Cell Lymphoma In Combination Of Belinostat (Beleodaq) And Standard CHOP

  December 7, 2015

   · 

  12 min read